These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 25043692)
1. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells. Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692 [TBL] [Abstract][Full Text] [Related]
2. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta. Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105 [TBL] [Abstract][Full Text] [Related]
3. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia. Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708 [TBL] [Abstract][Full Text] [Related]
4. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion. Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507 [TBL] [Abstract][Full Text] [Related]
5. Oxysterol-induced soluble endoglin release and its involvement in hypertension. Valbuena-Diez AC; Blanco FJ; Oujo B; Langa C; Gonzalez-Nuñez M; Llano E; Pendas AM; Díaz M; Castrillo A; Lopez-Novoa JM; Bernabeu C Circulation; 2012 Nov; 126(22):2612-24. PubMed ID: 23110859 [TBL] [Abstract][Full Text] [Related]
6. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction. Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779 [TBL] [Abstract][Full Text] [Related]
7. Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14. Kaitu'u-Lino TJ; Hastie R; Cannon P; Nguyen H; Lee S; Hannan NJ; Tong S Placenta; 2015 Aug; 36(8):932-7. PubMed ID: 26145228 [TBL] [Abstract][Full Text] [Related]
8. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro. Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236 [TBL] [Abstract][Full Text] [Related]
9. Loss of Akt increases soluble endoglin release from endothelial cells but not placenta. Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Brownfoot F; De Silva M; Cannon P; Tuohey L; Tong S Pregnancy Hypertens; 2016 Apr; 6(2):95-102. PubMed ID: 27155335 [TBL] [Abstract][Full Text] [Related]
10. YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia. Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Tuohey L; Kaitu'u-Lino TJ Mol Cell Endocrinol; 2015 Sep; 413():202-8. PubMed ID: 26159901 [TBL] [Abstract][Full Text] [Related]
11. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia. Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761 [TBL] [Abstract][Full Text] [Related]
13. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265 [TBL] [Abstract][Full Text] [Related]
14. IFI16 mediates soluble Flt-1 and endoglin production by trophoblast cells. Li N; Fu Y; Chen W; Hu GQ; Zhou M; Yu SX; Zhang XJ; Du CT; Yang YJ J Hypertens; 2015 Aug; 33(8):1658-65. PubMed ID: 26002845 [TBL] [Abstract][Full Text] [Related]
15. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies. Gu Y; Lewis DF; Wang Y J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952 [TBL] [Abstract][Full Text] [Related]
17. MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin. Kaitu'u-Lino TJ; Palmer K; Tuohey L; Ye L; Tong S PLoS One; 2012; 7(6):e39864. PubMed ID: 22768148 [TBL] [Abstract][Full Text] [Related]
18. Oxidative stress-induced S100B protein from placenta and amnion affects soluble Endoglin release from endothelial cells. Tskitishvili E; Sharentuya N; Temma-Asano K; Mimura K; Kinugasa-Taniguchi Y; Kanagawa T; Fukuda H; Kimura T; Tomimatsu T; Shimoya K Mol Hum Reprod; 2010 Mar; 16(3):188-99. PubMed ID: 19939849 [TBL] [Abstract][Full Text] [Related]
19. Gadd45α as an upstream signaling molecule of p38 MAPK triggers oxidative stress-induced sFlt-1 and sEng upregulation in preeclampsia. Luo X; Yao ZW; Qi HB; Liu DD; Chen GQ; Huang S; Li QS Cell Tissue Res; 2011 Jun; 344(3):551-65. PubMed ID: 21519896 [TBL] [Abstract][Full Text] [Related]
20. Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia. Hannan NJ; Binder NK; Beard S; Nguyen TV; Kaitu'u-Lino TJ; Tong S PLoS One; 2018; 13(4):e0187082. PubMed ID: 29641523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]